Monoclonal antibody targeting BDC…lupus erythematosus.

🔬 Peer-reviewed

Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.

Furie R, Werth VP, Merola JF, Stevenson L, Reynolds TL et al.

The Journal of clinical investigation · 2019

Ingredients studied

Findings

PubMed study on Glycoproteins in cosmetics/dermatology

Design

Randomized Controlled Trial

Evidence

Moderate

Journal

The Journal of clinical investigation